BioCentury
ARTICLE | Company News

Endovasc cardiovascular news

May 30, 2005 7:00 AM UTC

EVSC will no longer fund research by its Angiogenix subsidiary, which has terminated its license to a preclinical nicotine receptor agonist (NRA) from Stanford University (Stanford, Calif.). The NRA l...